June, 2013

article thumbnail

Preview of Enrollment Analytics: Moving Beyond the Funnel (Shameless DIA Self-Promotion, Part 2)

Placebo Control

Are we looking at our enrollment data in the right way? I will be chairing a session on Tuesday on this topic, joined by a couple of great presenters (Diana Chung from Gilead and Gretchen Goller from PRA). Here's a short preview of the session: Hope to see you there. It should be a great discussion. Session Details: June 25, 1:45PM - 3:15PM Session Number: 241 Room Number: 205B 1.

article thumbnail

Pediatric Trial Enrollment (Shameless DIA Self-Promotion, Part 1)

Placebo Control

[ Fair Warning: I have generally tried to keep this blog separate from my corporate existence, but am making an exception for two quick posts about the upcoming DIA 2013 Annual Meeting.] Improving Enrollment in Pediatric Clinical Trials Logistically, ethically, and emotionally, involving children in medical research is greatly different from the same research in adults.

Trials 40
article thumbnail

Can FDA's New Transparency Survive Avandia?

Placebo Control

PDUFA V commitments signal a strong commitment to tolerance of open debate in the face of uncertainty. I can admit to a rather powerful lack of enthusiasm when reading about interpersonal squabbles. It’s even worse in the scientific world: when I read about debates getting mired in personal attacks I tend to simply stop reading and move on to something else.

Trials 40